Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Germany”
Sponsor: GlaxoSmithKline
Multiple Myeloma
United States, France, Germany, Greece, Japan +3 more
Sponsor: Boehringer Ingelheim
Fibrosing Interstitial Lung Disease
United States, Argentina, Australia, Belgium, Brazil +17 more
Sponsor: AbbVie
Hidradenitis Suppurativa
United States, Argentina, Australia, Austria, Belgium +32 more
Sponsor: Merck Sharp & Dohme LLC
Leukemia, Lymphocytic, Chronic, B-Cell · Leukemia, Chronic Lymphocytic · Small-Cell Lymphoma · Lymphoma, Small Lymphocytic
United States, Argentina, Australia, Belgium, Brazil +13 more
Sponsor: UCB Biopharma SRL
Alzheimer's Disease
United States, Belgium, Canada, France, Germany +5 more
Sponsor: Merck Sharp & Dohme LLC
Hematologic Malignancies · Waldenstroms Macroglobulinaemia · Non-Hodgkins Lymphoma · Chronic Lymphocytic Leukaemia
United States, Argentina, Australia, Brazil, Canada +17 more
Sponsor: Debiopharm International SA
Acromegaly
United States, Austria, Belgium, Brazil, Bulgaria +16 more
- An Open-label, Study to Assess Safety, Efficacy and Cellular Kinetics of YTB323 in Severe, Refractory Systemic Lupus ErythematosusActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Systemic Lupus Erythematosus · Lupus Nephritis
Australia, France, Germany, Spain, Switzerland
- A Study of Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemolytic AnemiaActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Warm Autoimmune Hemolytic Anemia (wAIHA)
United States, Argentina, Australia, China, France +11 more
Sponsor: Amgen
Atherosclerotic Cardiovascular Disease · Overweight · Obesity
United States, Argentina, Australia, Austria, Belgium +31 more
- Phase 3 Study to Evaluate Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 2)Active Not Recruiting
Sponsor: Novartis Pharmaceuticals
Systemic Lupus Erythematosus
United States, Argentina, Australia, Chile, Colombia +10 more
- Avacostar - (PASS)Active Not Recruiting
Sponsor: Vifor Fresenius Medical Care Renal Pharma
ANCA-associated Vasculitis
Germany, United Kingdom
- A Study of Acalabrutinib vs Investigator's Choice of Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in R/R CLLActive Not Recruiting
Sponsor: Acerta Pharma BV
Chronic Lymphocytic Leukemia
United States, Australia, Austria, Belgium, Bulgaria +20 more
Sponsor: Biotest
Community-acquired Pneumonia
United States, Argentina, Australia, Austria, Belgium +13 more
- A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of GM1 Gangliosidosis or GM2 GangliosidosisActive Not Recruiting
Sponsor: Azafaros B.V.
Gangliosidoses, GM2 · Gangliosidosis, GM1
United States, Argentina, Australia, Brazil, Canada +9 more
Sponsor: Crinetics Pharmaceuticals Inc.
Congenital Adrenal Hyperplasia · Classic Congenital Adrenal Hyperplasia
United States, Argentina, Australia, Belgium, Brazil +6 more
Sponsor: Philogen S.p.A.
Locally Advanced Cutaneous Squamous Cell Carcinoma
United States, Germany, Greece, Italy, Spain
Sponsor: Boston Scientific Corporation
Cardiac Disease
Belgium, Canada, France, Germany, Greece +5 more
- A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS)Active Not Recruiting
Sponsor: Hoffmann-La Roche
Multiple Sclerosis
United States, Argentina, Belgium, Brazil, Bulgaria +17 more
- DAREON®-36: A Study to Test Obrixtamig in Combination With ZL-1310 in People With Advanced Small Cell Lung Cancer or Other Neuroendocrine CancersNot Yet Recruiting
Sponsor: Boehringer Ingelheim
Small Cell Lung Cancer · Large Cell Neuroendocrine Lung Carcinoma · Extrapulmonary Neuroendocrine Carcinoma of Small Cell Histology · Extrapulmonary Neuroendocrine Carcinoma of Large Cell Histology
United States, Australia, Belgium, China, France +6 more
Sponsor: Kedrion S.p.A.
Chronic Primary Immune Thrombocytopenia (ITP)
United States, Czechia, Germany, Italy, Romania +3 more
Sponsor: Italfarmaco
Duchenne Muscular Dystrophy
Belgium, Canada, Czechia, France, Germany +7 more
Sponsor: Boehringer Ingelheim
Non-small Cell Lung Cancer
United States, Argentina, Australia, Austria, Belgium +23 more
Sponsor: AbbVie
Neovascular Age-related Macular Degeneration
United States, Austria, Belgium, Bulgaria, Canada +12 more
- A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma ExacerbationsActive Not Recruiting
Sponsor: Teva Branded Pharmaceutical Products R&D LLC
Asthma
United States, Argentina, Australia, Bulgaria, Canada +17 more